H.JengT
Patches are being designed as self-applied transdermal systems that are placed on the skin to release medication gradually over time
Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding
During World War II, a Nutrition Professor at Cornell University, Dr
Personal health insurance plans, on the other hand, rarely include coverage for weight loss medications and often exclude them altogether
